2023 (1)

• Hirschberg, S., Ghazaani, F., Ben Amor, G., Pydde, M., Nagel, A., Germani, S., Monica, L., Schlör, A., Bauer, H., Hornung, J., Voetz, M., Dwai, Y., Scheer, B., Ringel, F., Kamal-Eddin, O., Harms, C., Füner, J., Adrian, L., Pruß, A., Schulze-Forster, K., Hanack, K., Kamhieh-Milz, J. (2023):
  An efficient and scalable method for the production of immunogenic SARS-CoV-2 virus-like particles (VLP) from a mammalian suspension cell line
  Vaccines 11 (9), art. 1469 10.3390/vaccines11091469

2022 (1)

• Vasileiadis, S., Perruchon, C., Scheer, B., Adrian, L., Steinbach, N., Trevisan, M., Plaza-Bolaños, P., Agüera, A., Chatzinotas, A., Karpouzas, D.G. (2022):
  Nutritional inter-dependencies and a carbazole-dioxygenase are key elements of a bacterial consortium relying on a Sphingomonas for the degradation of the fungicide thiabendazole
  Environ. Microbiol. 24 (11), 5105 - 5122 10.1111/1462-2920.16116

2017 (1)

• Kadisch, M., Julsing, M.K., Schrewe, M., Jehmlich, N., Scheer, B., von Bergen, M., Schmid, A., Bühler, B. (2017):
  Maximization of cell viability rather than biocatalyst activity improves whole-cell ω-oxyfunctionalization performance
  Biotechnol. Bioeng. 114 (4), 874 - 884 10.1002/bit.26213